Tag:

Vaccines

RFK Jr. Considering Dropping Longshot Presidential Bid To Help Trump, Report Says RFK Jr. Considering Dropping Longshot Presidential Bid To Help Trump, Report Says
RFK Jr. Considering Dropping Longshot Presidential Bid To Help Trump, Report Says The chances of seeing another Kennedy back in the White House next year appear to be growing even thinner. Robert F. Kennedy Jr. is considering dropping his longshot presidential bid in an effort to boost former President Donald Trump’s chances of winning, his running mate, Nicole Shanahan, told the Impact Theory podcast. In the interview, which was recorded on Monday, Aug. 19 and publicized the following day, Shanahan said the independent campaign is currently considering two options going forward. Earlier Report: Kennedy Appeals Ruling in NY Ballot Access Residency Case Involving Katon…
Surge In COVID-19, Flu, RSV Hospitalizations Leads To Winter Virus Warning By CDC Surge In COVID-19, Flu, RSV Hospitalizations Leads To Winter Virus Warning By CDC
Surge In Covid-19, Flu, RSV Hospitalizations Leads To Winter Virus Warning By CDC The Centers for Disease Control and Prevention (CDC) is sounding the alarm, warning that low vaccination rates for COVID-19, influenza, and RSV (respiratory syncytial virus) could strain healthcare systems across the nation in the weeks ahead. Hospitalizations among all age groups in the last month increased by 200 percent for influenza, 51 percent for COVID, and 60 percent for RSV, the CDC said. Meanwhile, coverage for the seasonal 2023-2024 flu shot is low in all age groups compared with the same period of the 2022–2023 season. Just 17 percent of adults had received the updated COVID vac…
COVID-19: FDA Approves Updated Booster Shots Targeting New Variants COVID-19: FDA Approves Updated Booster Shots Targeting New Variants
Covid-19: FDA Approves Updated Booster Shots Targeting New Variants Health officials are one step closer to rolling out updated COVID-19 vaccines just in time for a rise in cases heading into the fall and winter months. The US Food and Drug Administration (FDA) approved new vaccines on Monday, Sept. 11, that are meant to better target currently circulating COVID-19 variants and provide better protection against hospitalization and death, the agency announced. Monday’s move affects vaccines manufactured by Moderna and Pfizer. The updated mRNA vaccines are each approved for people ages 12 and older and are authorized under emergency use for children ages 6 mo…